These Healthcare stocks are trading higher:
-Hoth Therapeutics Inc (HOTH) stock is trading at $1.39, a rise of $0.68, or 97.28%, on high volume. Hoth Therapeutics Inc gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $5.00.
-NLS Pharmaceutics AG (NLSP) stock is trading at $1.88, an increase of $0.69, or 52.98%, on high volume. Nls Pharmaceutics Ltd gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $10.00.
-Plus Therapeutics Inc (PSTV) stock is trading at $1.25, an increase of $0.16, or 19.18%, on high volume. Plus Therapeutics Inc gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $7.00. Plus Therapeutics Inc next reports earnings on January 19.
-Aravive Inc (ARAV) stock is trading at $2.75, an increase of $0.3, or 12.65%, on high volume. Aravive Inc gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $22.00. Aravive Inc next reports earnings on January 26.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Gritstone bio Inc (GRTS) stock is trading at $7.28, a loss of $4.91, or 40.12%, on high volume. Gritstone Bio Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $22.00. Gritstone Bio Inc next reports earnings on February 1.-Avrobio Inc (AVRO) stock is trading at $2.73, a drop of $1.31, or 32.5%, on high volume. Avrobio Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $20.00. Avrobio Inc next reports earnings on February 2.
-Biolife Sciences Inc (BLFE) stock is trading at $1.29, a loss of $0.62, or 32.46%, on high volume. Biolife Sciences Inc gets a Sentiment Score of Very Bullish from InvestorsObserver.
-iCAD Inc (ICAD) stock is trading at $5.80, a loss of $1.68, or 22.46%, on high volume. Icad Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $22.25.
